Resumo

GARCIA LUQUE, A.; PUERRO VICENTE, M.; PRATS OLIVAN, P.  e  GONZALEZ ALFONSO, M.. Positive assessment of drugs: 2^nd quarter 2013. Sanid. Mil. [online]. 2013, vol.69, n.3, pp.206-209. ISSN 1887-8571.  https://dx.doi.org/10.4321/S1887-85712013000300008.

The drugs assessed by the Spanish Agency for Medicines and Health Products made public in the second quarter of 2013, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.

Palavras-chave : Avanafilo; Spedra; Erectile dysfunction; Dextromethorphan hydrobromide; Quinidine Sulfate; Nuedexta; Pseudobulbar involvement; Enzalutamida; Xtandi; Resistant metastatic prostate cancer; Human coagulation factor VIII; Von Willebrand Factor Human; Voncento; Autologous chondrocyte implantation; Maci; Lipegfilgrastim; Lonquex; Neutropenia; Lomitapida; Lojuxta; Homozygous familial hypercholesterolemia; Pomalidomide; Pomalidomide Celgene; Relapsed and refractory multiple myeloma; Somatropin; Somatropin Biopartners; Growth retardation; Modified Virus Ankara Vaccine; Imvanex; Smallpox; Vismodegib; Erivedge; Metastatic basal cell carcinoma.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )